Defining the First Part of the Oncogenic KRAS Journey

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Discovered as a proto-oncogene 40 years ago, mutations in KRAS exist in ∼30% of all human cancers. In this issue of Cell Stem Cell, Dost et al. (2020) combine the power of analyzing organoid cultures, patient samples, and mouse models with scRNA-seq to elucidate early events occurring with oncogenic KRAS activation.

Original languageEnglish (US)
Pages (from-to)499-500
Number of pages2
JournalCell Stem Cell
Issue number4
StatePublished - Oct 1 2020

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Cell Biology


Dive into the research topics of 'Defining the First Part of the Oncogenic KRAS Journey'. Together they form a unique fingerprint.

Cite this